Asociacion Centro de Investigacion Cooperativa en Biociencias

Asociacion Centro de Investigacion Cooperativa en Biociencias is a research organisation in Derio Vizcaya, Spain that has taken part in 58 EU-funded projects since 2008, receiving €28.0M in EU funding and leading 30 as coordinator.

EU funding received€28.0M
EU projects58
As coordinator30
Running now20
First EU project2008
Latest project2027
CountrySpain
EU registration (PIC)998817731
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Asociacion Centro de Investigacion Cooperativa en Biociencias's own share of each project, not the project's full budget.

  • Horizon Europe€12.8M · 30 projects
  • Horizon 2020€12.5M · 22 projects
  • FP7 (2007 to 2013)€2.6M · 6 projects

Projects

58 EU-funded projects, newest first. Asociacion Centro de Investigacion Cooperativa en Biociencias led 30 of them as coordinator. Each links to the official record.

  • GLYCODECD44Coordinator

    Unravelling Glycosylation Codes in Cancer at the Molecular Level: An Interdisciplinary Approach for the Dissection of the Recognition Features of CD44 by Galectins and Selectins

    Horizon Europe · 2027–2029 · Project on CORDIS ↗

    €194ktheir share
  • GlycoScopeCoordinator

    Glycoproteins with homogeneous glycosylation to define unexplored lectin binding properties

    Horizon Europe · 2027–2029 · Project on CORDIS ↗

    €194ktheir share
  • ProofReadingCoordinator

    European doctoral network for proofreading the proteome

    Horizon Europe · 2027–2030 · Project on CORDIS ↗

    €564ktheir share
  • GlyCaBiotaPartner

    Doctoral Training Network on Glycan–Cancer–Microbiota Interactions for Therapeutic and Diagnostic Innovation in Colorectal cancer

    Horizon Europe · 2027–2030 · Project on CORDIS ↗

    €282ktheir share
  • VaccinNateCoordinator

    From adjuvants-based vaccines for inflammatory diseases to refined vaccine adjuvants

    Horizon Europe · 2026–2028 · Project on CORDIS ↗

    €194ktheir share
  • RGNcestryPartner

    Tracing and harnessing the ancestry of RNA-guided nucleases

    Horizon Europe · 2026–2032 · Project on CORDIS ↗

    €2.4Mtheir share
  • EVADEREPartner

    Enhanced VAccines DEsign against antimicrobial REsistance

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €282ktheir share
  • UnMissCoordinator

    Uncovering the hidden origin behind the missing heritability

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

    €2.0Mtheir share
  • IMMUFELLOWAssociated partner

    Interdisciplinary and Intersectoral Research Fellowship Program for Future Leaders in Immunology

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

  • BiParatopicCoordinator

    Bispecific bi-paratopic antibodies for the treatment of cancer

    Horizon Europe · 2025–2026 · Project on CORDIS ↗

    €150ktheir share
  • InFlaMePartner

    Counter-acting the pandemic potential of flaviviruses: addressing virus-host interactions and defense strategies to design new therapeutics against WNV and DENV

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €625ktheir share
  • CARAMELPartner

    CArdiovascular Risk Assessment in MEnopausaL women via multimodal data analysis enabling personalized prevention strategies

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €816ktheir share
  • ADJUPROBECoordinator

    LEAD ADJUVANT PROBE AS A DUAL TECHNOLOGICAL TOOL TO ADVANCE NEXT-GENERATION VACCINE DEVELOPMENT

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

    €150ktheir share
  • MagFetProgCoordinator

    Magnesium and fetal metabolic programming: an approach to preventing a life-cycle of metabolic diseases

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €194ktheir share
  • EPIMemoryCoordinator

    Epithelial Memory to Candida albicans during commensalism and infection

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

    €165ktheir share
  • SPIRALCoordinator

    Structural exploration of GD3 ganglioside-COVID spike Protein Interaction and siglec-7 Role in inhibition of virAL infection

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

    €169ktheir share
  • ADJU-PLATFORMCoordinator

    MINIMAL SAPONIN-BASED ADJUVANT VACCINE PLATFORM

    Horizon Europe · 2024–2025 · Project on CORDIS ↗

    €150ktheir share
  • ENSCCPartner

    European Network on the Supramolecular Chemistry of Carbohydrates

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €252ktheir share
  • GLYCO-NPartner

    GLYCOprotein N-glycosylation from non-life to eukaryotes: a Doctoral Network to expand the knowledge on a ubiquitous posttranslational modification of proteins

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €252ktheir share
  • PLIADESPartner

    AI-Enabled Data Lifecycles Optimization and Data Spaces Integration for Increased Efficiency and Interoperability

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €203ktheir share
  • Glyco13CellCoordinator

    Isotopically labelling of cell surface glycans to illuminate infectious processes at atomic resolution

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €1.5Mtheir share
  • CARESCoordinator

    Human ECM-based platform for anti-cancer drug testing - CARES (CAncer dRug tESting)

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €51ktheir share
  • ADJUVACCINECoordinator

    Development of a marketable adjuvant candidate for vaccine applications

    Horizon Europe · 2023–2024 · Project on CORDIS ↗

    €150ktheir share
  • CoDietPartner

    COMBATTING DIET RELATED NON-COMMUNICABLE DISEASE THROUGH ENHANCED SURVEILLANCE

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €406ktheir share
  • GLYCOTwinningPartner

    GLYCOTwinning: Building Networks to Excel in Glycosciences

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €234ktheir share
  • halt-RONINPartner

    Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €535ktheir share
  • EVCAPartner

    Centre for Excellence in Diagnostic and Advanced Therapeutics based on Extracellular Vesicles

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €208ktheir share
  • R-NMRPartner

    Remote NMR (R-NMR): Moving NMR infrastructures to remote access capabilities

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €50ktheir share
  • SPIDVACPartner

    Improved control of priority animal diseases: Novel vaccines and companion diagnostic tests for African horse sickness, peste des petits ruminants and foot-and-mouth disease

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €294ktheir share
  • FIH-IOCoordinator

    Development of a first-in-class inhibitor of FIH for cancer immunotherapy

    Horizon Europe · 2022–2023 · Project on CORDIS ↗

    €150ktheir share
  • CD28Coordinator

    Probing CD28 as checkpoint for T cell co-stimulation in cancer and infection

    Horizon 2020 · 2021–2024 · Project on CORDIS ↗

    €246ktheir share
  • PIPgenPartner

    PI3K/PTEN-related monogenic disease to understand cancer

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €251ktheir share
  • BioUPGRADEPartner

    Biocatalytic upgrading of natural biopolymers for reassembly as multipurpose materials

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €501ktheir share
  • GLYTUNESPartner

    A multidisciplinary training network for the bioinspired development of glycomimetics tuning the Siglec-Sialoglycan axis

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €251ktheir share
  • MyeRIBOPartner

    Deconstructing the Translational Control of Myelination by Specialized Ribosomes

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €14ktheir share
  • QS21-MechCoordinator

    Target identification and elucidation of the molecular mechanism of action of saponin vaccine adjuvants QS-21 (QS21Mech)

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €173ktheir share
  • CancerADAPTCoordinator

    Targeting the adaptive capacity of prostate cancer through the manipulation of transcriptional and metabolic traits

    Horizon 2020 · 2019–2025 · Project on CORDIS ↗

    €2.0Mtheir share
  • proEVLifeCyclePartner

    The life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €251ktheir share
  • BactiVaxPartner

    anti-Bacterial Innovative Vaccine Training Network.

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €502ktheir share
  • GlycoMabsCoordinator

    Chemoenzymatic glyco-engineering of therapeutic monoclonal antibodies

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €161ktheir share
Show 18 more projects
  • NextGen IOCoordinator

    Exploiting the hypoxia response in T cells for Next-Generation Immuno-Oncology

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €2.0Mtheir share
  • RECGLYCANMRCoordinator

    Breaking the limits in glycan recognition by NMR

    Horizon 2020 · 2018–2024 · Project on CORDIS ↗

    €2.5Mtheir share
  • UbiCODEPartner

    European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €248ktheir share
  • LITMUSPartner

    Liver Investigation: Testing Marker Utility in Steatohepatitis

    Horizon 2020 · 2017–2024 · Project on CORDIS ↗

    €403ktheir share
  • MetaboMARKERCoordinator

    A metabolism-based prognostic biomarker for prostate cancer

    Horizon 2020 · 2017–2018 · Project on CORDIS ↗

    €150ktheir share
  • ADJUV-ANT VACCINESCoordinator

    Elucidating the Molecular Mechanisms of Synthetic Saponin Adjuvants and Development of Novel Self-Adjuvanting Vaccines

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €1.5Mtheir share
  • TRAINPartner

    Tribbles Research and Innovation Network

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €297ktheir share
  • FCSSSLPCoordinator

    First Chemoselective Synthesis and Structural Studies of Lasso Peptides

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

    €257ktheir share
  • GLYCOVAXPartner

    A training network for the rational design of the next generation of well-defined glycoconjugate vaccines

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €248ktheir share
  • SchmaVirusVacDiagCoordinator

    Novel vaccine and diagnostic strategies against Schmallenberg virus

    Horizon 2020 · 2015–2017 · Project on CORDIS ↗

    €158ktheir share
  • ACMCoordinator

    Cholesterol metabolism as a driver of prostate cancer aggressiveness

    Horizon 2020 · 2015–2017 · Project on CORDIS ↗

    €158ktheir share
  • TOLLerantPartner

    Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach.

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

    €248ktheir share
  • THE NASCENT CODECoordinator

    Unravelling the Nascent Code: Signals sensed and transmitted by the nascent chain to acquire its functional state or reprogram gene expression

    FP7 (2007 to 2013) · 2014–2018 · Project on CORDIS ↗

    €100ktheir share
  • ANTIDOTEPartner

    Anti-tick Vaccines to Prevent Tick-borne Diseases in Europe

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €373ktheir share
  • CANCERMETABCoordinator

    Metabolic requirements for prostate cancer cell fitness

    FP7 (2007 to 2013) · 2013–2019 · Project on CORDIS ↗

    €1.5Mtheir share
  • PTENLKB1Coordinator

    Implication of energy sensing pathways in prostate cancer biology

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €100ktheir share
  • UPSTREAMCoordinator

    European Research Training in the Ubiquitin Proteasome System

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €256ktheir share
  • NANOTHERPartner

    Integration of Novel Nanoparticle based Technology for Therapeutics and Diagnosis of different types of Cancer

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €288ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • agriculture
  • alkaline earth metals
  • allergology
  • amorphous semiconductors
  • animal husbandry
  • antibiotic resistance
  • antibiotics
  • antivirals
  • artificial intelligence
  • asthma
  • bacteriology
  • biochemistry
  • biological interactions

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime